BPC-157 (Cognitive Applications)
BPC-157 (Cognitive Applications)
Also known as: BPC-157, Bepecin, PL-10, PL 14736
Overview
Key Facts
Primary Goal: Research and therapeutic applications of BPC-157 (Cognitive Applications)
Modulates the dopamine D1 and D2 receptor systems, counteracting dopamine agonist and antagonist-induced disturbances. Promotes nitric oxide (NO) system mediated neuroprotection and angiogenesis in neural tissue.
Dosing Information
~4-6 hours (estimated from animal pharmacokinetic data)
200–500 mcg
1-2 times daily
4-12 weeks
Benefits
- Neuroprotective effects in traumatic brain injury models
- Modulation of the dopaminergic system, counteracting dopamine-related damage
- Promotes peripheral nerve regeneration and repair
- Counteracts serotonin and dopamine system disturbances caused by various agents
- Demonstrated GABAergic system interaction supporting anxiolytic-like effects
- Cytoprotective effects extend to CNS neurons
Side Effects
Mechanism of Action
Modulates the dopamine D1 and D2 receptor systems, counteracting dopamine agonist and antagonist-induced disturbances
Promotes nitric oxide (NO) system mediated neuroprotection and angiogenesis in neural tissue
Activates FAK-paxillin pathway to support nerve cell survival and regeneration
Interacts with the GABAergic system, contributing to anxiolytic and mood-stabilizing effects
Contraindications
Do not use this peptide if any of the following apply:
- Active malignancy, particularly CNS tumours
- Pregnancy or breastfeeding
- Currently taking dopamine-modulating medications (potential for interaction)
Storage & Reconstitution
Unreconstituted (Powder)
Reconstituted (Mixed)
Research Summary
BPC-157 has been studied extensively in preclinical models for its neuroprotective properties beyond its well-known tissue healing effects. Research published in journals including Current Neuropharmacology and Regulatory Peptides has demonstrated its ability to counteract dopaminergic neurotoxicity (amphetamine, haloperidol), protect against traumatic brain injury, and promote peripheral nerve regeneration following transection injuries. Its interaction with the NO system and dopamine pathways makes it relevant to cognitive function, though human clinical trials for cognitive indications have not been conducted.
Frequently Asked Questions
Common questions about BPC-157 (Cognitive Applications)
UK-Specific Information
Exclusive data points and guidance for UK residents using BPC-157 (Cognitive Applications)
UK Lab Testing
UK Lab Testing
Recommended labs: Medichecks, Thriva (£89-£149 for peptide safety panel)
Why this matters: UK-specific lab testing guidance not available on US competitor sites
Commonly Stacked With
5-Amino-1MQ
Research and therapeutic applications of 5-Amino-1MQ
Ac-SDKP
Research and therapeutic applications of Ac-SDKP
ACE-031
Research and therapeutic applications of ACE-031
Acetyl Hexapeptide-3
Research and therapeutic applications of Acetyl Hexapeptide-3
AHK-Cu
Research and therapeutic applications of AHK-Cu
Alcohol Prep Pads
Research and therapeutic applications of Alcohol Prep Pads
Note: Peptide stacking should only be done under the guidance of a qualified healthcare professional. Individual responses may vary.
Share on TikTok
Generate a trackable link to share this peptide information on TikTok